# Study of Rifaximin in Minimal Hepatic Encephalopathy

> **NCT01069133** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hunter Holmes Mcguire Veteran Affairs Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Minimal Hepatic Encephalopathy

## Interventions

- **DRUG:** Rifaximin
- **DRUG:** rifaximin

## Key facts

- **NCT ID:** NCT01069133
- **Lead sponsor:** Hunter Holmes Mcguire Veteran Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069133, "Study of Rifaximin in Minimal Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01069133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*